C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2007
12/27/2007	WO2007148135A1 Macrocyclic compounds as antiviral agents
12/27/2007	WO2007126941A3 Solid support reagents for synthesis
12/27/2007	WO2007109118A9 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
12/27/2007	US20070299015 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/27/2007	US20070299014 Casein hydrolyzate, process for producing the same and use thereof
12/27/2007	US20070299013 Exosite-Directed Thrombin Inhibitors
12/27/2007	CA2657213A1 Peptide epoxyketones for proteasome inhibition
12/27/2007	CA2654884A1 Macrocyclic compounds as antiviral agents
12/26/2007	EP1870457A1 Dipeptide crystals and process for production thereof
12/26/2007	EP1870419A2 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
12/26/2007	EP1869068A1 Antibacterial amide-macrocycles v
12/26/2007	EP1409518B1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
12/26/2007	CN101094861A Agonists and antagonists of the somatostatin receptor
12/26/2007	CN101094692A Improved quenching methods for red blood cell inactivation process
12/26/2007	CN101092455A Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/26/2007	CN100357314C Method for linking molecular substances
12/26/2007	CN100357270C D-proline derivative
12/26/2007	CN100357267C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
12/26/2007	CN100356981C Ligand oligopeptide specific combining human epidermal growth factor receptor EGFR
12/25/2007	US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007	US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease
12/25/2007	US7312306 Wound healing agents; anticoagulants
12/25/2007	US7312192 For treating diseases including diabetes
12/25/2007	US7312188 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP)
12/21/2007	WO2007146331A1 Tannate salt form of polypeptide mixtures, their preparation and use
12/21/2007	WO2007146269A2 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/21/2007	WO2007145208A1 Peptide derivative
12/21/2007	WO2007144979A1 Peptide derivative
12/21/2007	WO2007123839A3 Peptides with efficacy in rescuing melanocortin-4 receptor polymorphic agonist signaling
12/21/2007	WO2007116276A3 Integrin binding rgd-lipopeptides with gene transfer activities
12/21/2007	WO2007064997A3 Compounds and methods for inhibiting apoptosis
12/21/2007	CA2835369A1 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/21/2007	CA2655116A1 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/20/2007	US20070293442 Antithrombotic compound
12/20/2007	US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007	US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/19/2007	EP1866327A1 Improved process for preparation of highly pure trandolapril
12/19/2007	EP1866326A2 Immunogens for vaccines against antigenically variable pathogens and diseases
12/19/2007	EP1866291A1 Antibacterial amide macrocycles vi
12/19/2007	EP1866034A1 Substituted 1,2-ethylendiamines, medicaments comprising said compound; their use and their method of manufacture
12/19/2007	EP1095061B1 Peptides based on the sequence of human lactoferrin and their use
12/19/2007	CN101090977A Tripeptide and tetrapeptide thioethers
12/19/2007	CN101090909A Antibacterial amide macrocycles IV
12/18/2007	US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2007	US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007	US7309694 Gene therapy; cytokine complex; anticancer agent
12/18/2007	US7309595 Comprises protease for use in generating proline rich protein hydrolysate for use in food and drink to decrease allergenicity, facilitate gastrointestinal uptake and to stabilize proteins in acid products against precipitation during prolonged storage
12/18/2007	CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use
12/18/2007	CA2179562C Peptide useful in the separation and purification of immunoglobulins
12/13/2007	WO2007143694A2 Macrocyclic oximyl hepatitis c protease inhibitors
12/13/2007	WO2007142986A2 Aminothiazole derivatives and their uses as antibacterial agents
12/13/2007	WO2007142926A1 Method to treat blood cell depletion
12/13/2007	WO2006076255A3 Method of treating or preventing microbial eye infection
12/13/2007	WO2005039505A3 Compositions and methods for healthy pregnancy
12/13/2007	US20070287672 Macromolecular Gsh-Activiated Glyoxylase I Inhibitors
12/13/2007	US20070287671 Compositions and Methods for Promoting Myocardial and Peripheral Angiogenesis
12/13/2007	US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
12/13/2007	US20070287152 Labeling Substance and Chimera Substance, Process for Preparing These Substances, and Method of Biosubstance Trapping, Structural Analysis or/and Identification with Use of the Labeling Substance
12/13/2007	US20070286906 Dihydrobenzoquinone compounds
12/13/2007	CA2650133A1 Aminothiazole derivatives and their uses as antibacterial agents
12/12/2007	EP1865052A2 Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
12/12/2007	EP1864994A1 Par-2 agonist
12/12/2007	EP1863833A2 Process for preparing macrocyclic compounds
12/12/2007	EP1863832A1 Age inhibitors
12/12/2007	EP1743034B1 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof
12/12/2007	EP1644403B1 Cytotoxic depsipeptides
12/12/2007	EP0932606B1 Inhibitors of prenyl transferases
12/12/2007	EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
12/12/2007	CN100354628C Epitopes formed by non-covalent association of conjugates
12/12/2007	CN100354019C Production of crystalline materials by using high intensity ultrasound
12/11/2007	US7307063 Melanocortin metallopeptides for treatment of sexual dysfunction
12/11/2007	US7306931 Method for refolding proteins containing free cysteine residues
12/11/2007	CA2393271C Retroviral protease inhibiting compounds
12/11/2007	CA2221865C Bradykinin analogs as selective thrombin inhibitors
12/06/2007	WO2007140117A1 Compounds and compositions as channel activating protease inhibitors
12/06/2007	WO2007139921A2 N-oxides of kappa opioid receptor peptides
12/06/2007	WO2007139435A1 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application
12/06/2007	WO2007139433A1 Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application
12/06/2007	WO2007139431A1 Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application
12/06/2007	WO2007139430A1 Peptide substance stimulating liver tissue regeneration, pharmaceutical composition on its base and the method of its application
12/06/2007	WO2007112352A3 Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
12/06/2007	WO2007109648A3 Compositions and methods for modulating store-operated calcium entry
12/06/2007	WO2007002534A3 Thrombospondin-1 derived peptides and treatment methods
12/06/2007	US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007	US20070282015 Novel Splice Variants of Human Dkkl1
12/06/2007	US20070281885 deactivate virally encoded enzymes which is for the replication of the virus; protease inhibitor for anti-hepatitis C viral treatment; including other active drugs as interferon, ribavarin, and adamantine
12/06/2007	US20070281884 Macrocyclic oximyl hepatitis C protease inhibitors
12/06/2007	CA2653077A1 N-oxides of kappa opioid receptor peptides
12/06/2007	CA2651043A1 Compounds and compositions as channel activating protease inhibitors
12/05/2007	EP1861497A1 Protein and its use in diagnosing alzheimer's disease
12/05/2007	EP1635692A4 Monitoring immunologic, hematologic and inflammatory diseases
12/05/2007	CN101084240A MyD88 homodimerization inhibitors
12/05/2007	CN101084236A Prodrugs of excitatory amino acids
12/05/2007	CN100352935C Method for producing dipeptide
12/04/2007	US7304129 Peptides that stimulate cell survival and axon regeneration
12/04/2007	US7304128 High affinity and specificity, separation and immobilization of these structures for the fabrication of nano-devices
12/04/2007	US7304053 Glycoprotein-mediated MDR
12/04/2007	US7304037 Cytostatic conjugates with integrin ligands
12/04/2007	US7304032 CD-10 activated prodrug compounds
12/04/2007	US7303887 Identifying an agent that inhibits binding of mammalian Mcl-1 with a human or mouse Mule polypeptide having a Mule BH3 domain by contacting the mixture with a candidate agent and detecting an agent-biased binding that is different from the reference binding, indicating that the agent is an inhibitor

1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 307